| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 982.90K | 73.50K | 20.10K | 33.85K | 30.88K | 230.45K |
| Gross Profit | -453.90K | -452.70K | -1.06M | -1.97M | -1.49M | -1.06M |
| EBITDA | -5.62M | -5.38M | -4.00M | -7.30M | -6.81M | -2.68M |
| Net Income | -5.90M | -5.90M | -4.81M | -7.30M | -7.13M | -3.53M |
Balance Sheet | ||||||
| Total Assets | 19.45M | 19.45M | 22.83M | 26.91M | 33.93M | 16.53M |
| Cash, Cash Equivalents and Short-Term Investments | 7.98M | 7.98M | 11.95M | 15.87M | 23.45M | 9.82M |
| Total Debt | 470.70K | 470.70K | 625.30K | 618.48K | 847.60K | 827.72K |
| Total Liabilities | 2.27M | 2.27M | 2.47M | 2.14M | 2.50M | 2.34M |
| Stockholders Equity | 17.18M | 17.18M | 20.36M | 24.77M | 31.44M | 14.19M |
Cash Flow | ||||||
| Free Cash Flow | -5.09M | -6.28M | -4.13M | -7.45M | -10.08M | -4.95M |
| Operating Cash Flow | -4.02M | -4.18M | -2.46M | -6.05M | -5.64M | -2.13M |
| Investing Cash Flow | 2.07M | 2.47M | -5.06M | -1.40M | -4.44M | -2.83M |
| Financing Cash Flow | 1.93M | 1.93M | -316.70K | -75.78K | 23.71M | -32.94K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £138.84M | 24.91 | 15.77% | ― | -5.73% | ― | |
51 Neutral | £118.06M | -4.45 | -86.37% | ― | 732.03% | 12.60% | |
51 Neutral | £67.81M | -10.62 | -31.45% | ― | 265.67% | -16.50% | |
51 Neutral | £452.42M | -12.33 | -23.26% | ― | 12.58% | 12.39% | |
45 Neutral | £4.82M | -21.73 | -1.39% | ― | -10.88% | -122.05% |
Ilika plc has made significant progress in its solid-state battery technology, with key advancements in both its Stereax and Goliath product lines. The Stereax M300 micro-battery production line has been qualified for manufacturing at Cirtec Medical’s facility, marking a crucial step towards meeting the demand for medical-grade micro-batteries. Meanwhile, the Goliath 2Ah P1 cells have been validated by customer testing, and the company has secured a £1.25 million grant to support the development of automotive applications. The completion of an automated assembly line for Goliath batteries enhances production capabilities, positioning Ilika to release 10Ah prototypes by December 2025. Despite a decrease in revenue and an increase in EBITDA loss, these developments underscore Ilika’s commitment to advancing its battery technology and expanding its market presence.
Ilika plc has announced the completion of its Goliath automated pilot line, marking a significant milestone in its solid-state battery production capabilities. This development enables the company to deliver 10Ah and 50Ah battery prototypes to customers, supporting internal and commercial testing programs. The pilot line’s operational status enhances manufacturing yield and consistency, positioning Ilika to meet the demands of its stakeholders and advance its commercialization and licensing objectives. Collaborations with UK Battery Industrialisation Centre and other partners will further scale up production, particularly for automotive applications.
Ilika plc has announced the successful commissioning of its Goliath automated pilot line, marking a significant step in its solid-state battery production capabilities. This development allows Ilika to deliver solid-state battery prototypes to customers, enhancing manufacturing yield and consistency. The pilot line’s operational status supports the delivery of 10Ah and 50Ah battery prototypes for customer testing and validation, aligning with Ilika’s commercialisation strategy. The company plans to further scale production in collaboration with the UK Battery Industrialisation Centre and other partners, reinforcing its position in the battery technology industry and advancing towards its licensing objectives.
Ilika plc has announced the issuance of 30,000 new ordinary shares following the exercise of options under its share option schemes. These shares are expected to be admitted for trading on AIM by October 6, 2025. This move will increase the company’s total issued share capital to 180,832,175 ordinary shares, which will be used by shareholders for calculating their interest in the company. This development reflects Ilika’s ongoing efforts to enhance its financial structure and market presence.
Ilika plc announced the successful passing of all resolutions at its recent Annual General Meeting, reflecting strong shareholder support. The company also granted share options to its executive directors as part of its deferred Bonus Scheme, indicating a strategic move to align management interests with company performance.
Ilika plc has announced the commencement of its PRIMED solid-state battery programme, supported by key partners including Jaguar Land Rover and Oxford University. The programme aims to advance the commercialisation of Ilika’s solid-state battery technology by leveraging the UK Battery Industrialisation Centre’s facilities to scale up production. This initiative builds on previous successful projects and is expected to deliver critical outcomes such as prototype cells and a production scale model, positioning Ilika to accelerate the industrialisation of its Goliath technology for the electric vehicle market.